174 related articles for article (PubMed ID: 25898860)
1. The role of the SCN5A-encoded channelopathy in irritable bowel syndrome and other gastrointestinal disorders.
Verstraelen TE; Ter Bekke RM; Volders PG; Masclee AA; Kruimel JW
Neurogastroenterol Motil; 2015 Jul; 27(7):906-13. PubMed ID: 25898860
[TBL] [Abstract][Full Text] [Related]
2. Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome.
Beyder A; Mazzone A; Strege PR; Tester DJ; Saito YA; Bernard CE; Enders FT; Ek WE; Schmidt PT; Dlugosz A; Lindberg G; Karling P; Ohlsson B; Gazouli M; Nardone G; Cuomo R; Usai-Satta P; Galeazzi F; Neri M; Portincasa P; Bellini M; Barbara G; Camilleri M; Locke GR; Talley NJ; D'Amato M; Ackerman MJ; Farrugia G
Gastroenterology; 2014 Jun; 146(7):1659-1668. PubMed ID: 24613995
[TBL] [Abstract][Full Text] [Related]
3. Irritable bowel syndrome patients have SCN5A channelopathies that lead to decreased Na
Strege PR; Mazzone A; Bernard CE; Neshatian L; Gibbons SJ; Saito YA; Tester DJ; Calvert ML; Mayer EA; Chang L; Ackerman MJ; Beyder A; Farrugia G
Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G494-G503. PubMed ID: 29167113
[TBL] [Abstract][Full Text] [Related]
4. SCN5A variant that blocks fibroblast growth factor homologous factor regulation causes human arrhythmia.
Musa H; Kline CF; Sturm AC; Murphy N; Adelman S; Wang C; Yan H; Johnson BL; Csepe TA; Kilic A; Higgins RS; Janssen PM; Fedorov VV; Weiss R; Salazar C; Hund TJ; Pitt GS; Mohler PJ
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12528-33. PubMed ID: 26392562
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of the Scn5a-encoded voltage-gated sodium channel NaV 1.5 in the rat jejunum.
Beyder A; Gibbons SJ; Mazzone A; Strege PR; Saravanaperumal SA; Sha L; Higgins S; Eisenman ST; Bernard CE; Geurts A; Kline CF; Mohler PJ; Farrugia G
Neurogastroenterol Motil; 2016 Jan; 28(1):64-73. PubMed ID: 26459913
[TBL] [Abstract][Full Text] [Related]
6. SCN5A-C683R exhibits combined gain-of-function and loss-of-function properties related to adrenaline-triggered ventricular arrhythmia.
Steinberg C; Pilote S; Philippon F; Laksman ZW; Champagne J; Simard C; Krahn AD; Drolet B
Exp Physiol; 2021 Mar; 106(3):683-699. PubMed ID: 33480457
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal symptoms in families of patients with an SCN5A-encoded cardiac channelopathy: evidence of an intestinal channelopathy.
Locke GR; Ackerman MJ; Zinsmeister AR; Thapa P; Farrugia G
Am J Gastroenterol; 2006 Jun; 101(6):1299-304. PubMed ID: 16771953
[TBL] [Abstract][Full Text] [Related]
8. Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy.
Saito YA; Strege PR; Tester DJ; Locke GR; Talley NJ; Bernard CE; Rae JL; Makielski JC; Ackerman MJ; Farrugia G
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G211-8. PubMed ID: 19056759
[TBL] [Abstract][Full Text] [Related]
9.
Remme CA
Philos Trans R Soc Lond B Biol Sci; 2023 Jun; 378(1879):20220164. PubMed ID: 37122208
[TBL] [Abstract][Full Text] [Related]
10. Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects.
Remme CA
J Physiol; 2013 Sep; 591(17):4099-116. PubMed ID: 23818691
[TBL] [Abstract][Full Text] [Related]
11.
Strege PR; Mercado-Perez A; Mazzone A; Saito YA; Bernard CE; Farrugia G; Beyder A
Channels (Austin); 2019 Dec; 13(1):287-298. PubMed ID: 31262209
[No Abstract] [Full Text] [Related]
12. Inter-Regulation of K
Clatot J; Neyroud N; Cox R; Souil C; Huang J; Guicheney P; Antzelevitch C
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709127
[TBL] [Abstract][Full Text] [Related]
13. Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy.
Wilde AAM; Amin AS
JACC Clin Electrophysiol; 2018 May; 4(5):569-579. PubMed ID: 29798782
[TBL] [Abstract][Full Text] [Related]
14. Alterations of Nedd4-2-binding capacity in PY-motif of Na
Wang Y; Du Y; Luo L; Hu P; Yang G; Li T; Han X; Ma A; Wang T
Acta Physiol (Oxf); 2020 Jun; 229(2):e13438. PubMed ID: 31900993
[TBL] [Abstract][Full Text] [Related]
15. The Role of Ion Channels in Functional Gastrointestinal Disorders (FGID): Evidence of Channelopathies and Potential Avenues for Future Research and Therapeutic Targets.
Maqoud F; Tricarico D; Mallamaci R; Orlando A; Russo F
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446251
[TBL] [Abstract][Full Text] [Related]
16. Ion channelopathies in functional GI disorders.
Beyder A; Farrugia G
Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G581-G586. PubMed ID: 27514480
[TBL] [Abstract][Full Text] [Related]
17. Differential calcium sensitivity in Na
Abdelsayed M; Baruteau AE; Gibbs K; Sanatani S; Krahn AD; Probst V; Ruben PC
J Physiol; 2017 Sep; 595(18):6165-6186. PubMed ID: 28734073
[TBL] [Abstract][Full Text] [Related]
18. Frequency of Irritable Bowel Syndrome in Patients with Brugada Syndrome and Drug-Induced Type 1 Brugada Pattern.
Sarica AS; Bor S; Orman MN; Barajas-Martinez H; Juang JJ; Antzelevitch C; Hasdemir C
Am J Cardiol; 2021 Jul; 151():51-56. PubMed ID: 34034907
[TBL] [Abstract][Full Text] [Related]
19. Trafficking and localisation to the plasma membrane of Na
Dulsat G; Palomeras S; Cortada E; Riuró H; Brugada R; Vergés M
Biol Cell; 2017 Jul; 109(7):273-291. PubMed ID: 28597987
[TBL] [Abstract][Full Text] [Related]
20. Sodium channelopathy underlying familial sick sinus syndrome with early onset and predominantly male characteristics.
Abe K; Machida T; Sumitomo N; Yamamoto H; Ohkubo K; Watanabe I; Makiyama T; Fukae S; Kohno M; Harrell DT; Ishikawa T; Tsuji Y; Nogami A; Watabe T; Oginosawa Y; Abe H; Maemura K; Motomura H; Makita N
Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):511-7. PubMed ID: 24762805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
